Tenderwize
Wróć do wyszukiwania

Open-House non-exclusive rebate agreement for BeclometasonFormoterolGlycopyrronium

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen·Erfurt, Germany·Deadline Jan 31, 2027 · 157 days left·Open·Supplies·Framework
Zarejestruj się, aby zapisaćOpen documents
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff BeclometasonFormoterolGlycopyrronium (ATC-Code nach WHO: R03AL09)

46/100

Ocena szansy

Needs reviewMedium complexity
SuppliesFrameworkOpen
Skąd ta ocena?

Szansa

46 / 100

Złożoność

58 / 100

Czynniki ryzyka

Structured data says electronic submission is not allowed, while the notice text says communication and transmission oc...

Important participation documents are referenced but not fully provided in the extracted text, especially 'Anschreiben'...

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Jan 2027
  • Non-exclusive supply/rebate agreement for pharmaceutical products containing BeclometasonFormoterolGlycopyrronium (ATC R03AL09).
  • Open-House model: contract conclusion is open to all interested companies during the participation period if they meet and accept the conditions.
Pokaż pełne podsumowanie

This is an Open-House pharmaceutical supply arrangement for the active substance BeclometasonFormoterolGlycopyrronium (ATC R03AL09) with AOK PLUS. It is non-exclusive, open to all interested pharmaceutical companies that meet and accept the participation conditions. No contract value, minimum purchase volume, or guaranteed demand is stated. Participation documents are available via DTVP, but the extracted procurement documents were not provided for analysis, so document-based requirements may be incomplete.

Ryzyka

Structured data says electronic submission is not allowed, while the notice text says communication and transmission oc...

Important participation documents are referenced but not fully provided in the extracted text, especially 'Anschreiben'...

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Applicant must be a pharmaceutical undertaking within the meaning of § 4(18) AMG for the offered medicinal product.

Eligibility

  • The bidder must submit the self-declaration on the absence of exclusion grounds under §§ 123, 124 GWB.

Administrative

  • The bidder must submit the self-declaration regarding EU Russia sanctions (Art. 5k of Regulation (EU) 2022/576).

Kryteria udzielenia

Lot 1

No lot-specific award criteria stated; Open-House participation is based on meeting and accepting the stated conditions.

Zamawiający

Lokalizacja

Erfurt, DEU

Profil zamawiającego

Otwórz profil

Identyfikator

DE256878834

Działalność

Health

Części (1)

LOT-0001

Open-House non-exclusive rebate agreement for BeclometasonFormoterolGlycopyrronium

Supply lot for a non-exclusive pharmaceutical rebate agreement under § 130a(8) SGB V for the active substance BeclometasonFormoterolGlycopyrronium (ATC R03AL09). The arrangement is an Open-House model, so any interested pharmaceutical company meeting the conditions may participate. Place of performance is Dresden, Germany. Lot information comes from structured data and XML notice.

SuppliesFrameworkEU fundedElectronic submission

Lokalizacja

Dresden, Germany

Czas trwania

Jan 2025 - Jan 2027

Kategoria

Pharmaceutical products

Kryteria udzielenia

No lot-specific award criteria stated; Open-House participation is based on meeting and accepting the stated conditions.

Termin

Deadline Jan 31, 2027

Szczegóły zamówienia

Data publikacji
03 Dec 2024
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
738758-2024

Dokumenty (1)

Dokument zamówienia 1

Podobne przetargi

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3